GlobeNewswire

Fortum Deploys DigitalRoute Technology to Enable Data Driven Services Supporting Energy Sector Transformation

Del

European utility Fortum is driving digital transformation within the energy sector, together with DigitalRoute. Starting with a digital solution for energy trading, by deploying machine learning algorithms based on DigitalRoute's Data Optimization Platform, the companies are now taking the next steps in building data driven services within the energy sector.

STOCKHOLM, Sweden, Dec. 19, 2017 (GLOBE NEWSWIRE) -- DigitalRoute, the leading Data Integration and Data Management company, and key European energy provider, Fortum, have jointly announced the completion of a successful Proof of Concept project. Fortum is a leading clean-energy company offering electricity, heating and cooling solutions as well as driving the change for a cleaner world.

Fortum has been looking for an IoT enabling platform to develop data-driven solutions and has now chosen to partner with DigitalRoute. DigitalRoute's platform allows for real-time communication between assets, plants, data sources and business systems, resulting in optimal quality data, which can be utilized to simplify the deployment of new solutions and optimize key processes.

The recently completed Proof of Concept focused on optimizing two different operational processes, both highlighting the benefits of Data Quality; to secure high quality data and then apply machine learning in order to optimize trading decisions.

The Use Case showed how DigitalRoute's solution could be used to predict intraday prices on the Nordic Energy market using external and internal data. Direct integration between the DigitalRoute Data Optimization Platform and market data sources enabled this provider to gain increased operational control, speed and commercial agility.

Fortum's Vice President, Trading and Asset Optimization, Simon-Erik Ollus, observed: "In partnership with DigitalRoute, we can increase both our momentum in the market as well as our self-sufficiency. We can focus on simplifying the deployment of new solutions and optimizing business processes, enabling a fast time-to-market."

Fortum will now utilize the experiences from the Proof of Concept in other areas such as operation and maintenance optimization of charging infrastructure, Smart Living services and further solutions within energy trading.

DigitalRoute CEO Andreas Zartmann said: "Our technology is a game changer for cutting-edge utility providers and we are delighted that Fortum is working with us to demonstrate how energy companies can use it to turn innovations from an opportunity into a commercial success. We are also excited to partner with a visionary player in a fast-changing industry. Once again, this underlines the wide scope of challenges DigitalRoute's technology can address."

About DigitalRoute®

DigitalRoute has been providing new approaches to data integration and data management since 1999. Its technology offers high throughput and provides a unique degree of user configurability, processing all usage and statistical data extracted from networks of connected assets. This means customers gain greater cost efficiencies, improved time-to-market for new service offerings, the ability to monetize any data, and the means to enhance end-customer satisfaction. DigitalRoute makes network events available to the right systems in the right formats in the most appropriate volumes at the required times, without losing a single bit. This is the foundation from which multiple, mission-critical use-cases can be addressed.

Over 350 leading companies worldwide use DigitalRoute technology to meet their data management needs, including a number of OEM partners who use our platform as a central part of their own offerings. DigitalRoute is built on the core values of Expertise, Open-Mindedness and Commitment. With close to 200 employees, the company is headquartered in Stockholm, Sweden with regional offices in Gothenburg, Atlanta and Kuala Lumpur. DigitalRoute is a venture-backed, privately-held company.

For more information or interviews with Andreas Zartmann contact:

Sancha Brody, Media & Analyst Relations
Email: sancha.brody@digitalroute.com
Phone: +44 (0)7376 366855

https://www.facebook.com/DigitalRoute
https://twitter.com/digital_route
https://www.linkedin.com/company/36031?trk=tyah

DigitalRoute and MediationZone are registered trademarks of Digital Route AB. All other trademarks are the property of their respective owners.




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: DigitalRoute via Globenewswire

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors16.1.2019 07:00Pressemelding

Pyrrolobenzodiazepine-based antibody drug conjugate targets AXL, a receptor tyrosine kinase highly expressed in solid tumors LAUSANNE, Switzerland, Jan. 16, 2019 (GLOBE NEWSWIRE) -- ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of proprietary antibody drug conjugates (ADCs), today announced that the first patient has been dosed in its Phase I clinical trial evaluating the safety, tolerability, pharmacokinetics and anti-tumor activity of ADCT-601 in patients with selected solid tumors that are locally advanced or metastatic. ADCT-601 is an ADC composed of a humanized monoclonal antibody against human AXL, conjugated using GlycoConnect™ site specific conjugation technology to a pyrrolobenzodiazepine (PBD) dimer toxin. In preclinical studies, ADCT-601 demonstrated potent and specific in vitro and in vivo anti-tumor activity in multiple cancer-derived models with different levels of AXL expression, and was stable and well tolerated

GSA Europe’s Managing Director Elected Co-lead of CEN’s TC456 Committee15.1.2019 21:12Pressemelding

SAN GWANN, Malta, Jan. 15, 2019 (GLOBE NEWSWIRE) -- GSA Europe’s Managing Director Mark Pace has been elected by the Comité Européen de Normalisation (CEN) to lead the creation of a European Union online gaming reporting standard. CEN has established Technical Committee 456 to create this standard in support of online gambling supervision. GSA Europe joined Technical Committee 456 as a Liaison Organization in 2017. The Technical Committee’s mandate from the European Commission is directly aligned with work that GSA Europe has already started, namely, to create a single standard set of data elements and single standard way in which data is provided by online gambling providers to EU Member State regulatory authorities. In addition to joining and now leading the Technical Committee’s work, GSA Europe also donated their draft Regulatory Data Set and Regulatory Reporting Interface to CEN seeking to help jump-start the Committee’s work. “Joining CEN’s TC456 as a Liaison Organization, and no

Orion Biotechnology Reports Positive Results for Colorectal Cancer in Preclinical Study15.1.2019 15:00Pressemelding

OTTAWA, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Orion Biotechnology Canada Ltd., a developer of novel medical treatments, today announced preclinical data produced in collaboration with Charles River Laboratories, evaluating the efficacy of OB-002O (5P12-RANTES) in colorectal cancer. BALB/c mice were inoculated subcutaneously with the CT-26 colorectal cancer cell line. Three days after inoculation intraperitoneal treatment was started with OB-002O, a murine anti-PD-1 antibody, OB-002 + anti-PD-1, or saline placebo. Treatment was given daily or every third day. Treatment with OB-0020 alone led to statistically significant delayed tumor growth at multiple time-points. An even more profound effect on the decrease in mean tumor volume was observed in combination cohort where animals received both, OB-0020 and the anti-PD-1 antibody (p>0.05). “There is growing awareness of the role of CCR5 antagonism as an important component of cancer immunotherapy. OB-002O is an extremely potent CCR5 antagonist

Credit Suisse Partners with CGAP on Digital Finance to Catalyze Delivery of Energy, Water and other Services to Low Income People15.1.2019 14:08Pressemelding

Washington/Zurich, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Credit Suisse, one of the world's leading financial services providers, is partnering with the Consultative Group to Assist the Poor (CGAP) to support its work in building inclusive and responsible financial systems that help people move out of poverty, protect their economic gains and advance the broader global development agenda. CGAP is a global partnership of more than 30 leading development agencies, private foundations and national governments committed to financial inclusion as a means toward expanding opportunities for poor people. Through their engagement, CGAP and Credit Suisse will capitalize upon and leverage each other’s knowledge to further financial inclusion and its contribution toward achieving the United Nations’ Sustainable Development Goals (SDGs). Among the projects that align well with Credit Suisse’s expertise are CGAP’s work on sustainable business models that use digital finance technologies to lower the cost

TrueCommerce Recognized as a Leader in IDC MarketScape for Worldwide Multi-Enterprise Supply Chain Commerce Network15.1.2019 14:00Pressemelding

-- “The vendor offers a true partnership for their customers and has become an extension of their internal staff and resources to manage their supply chains,” says the report -- PITTSBURGH, Jan. 15, 2019 (GLOBE NEWSWIRE) -- TrueCommerce, a global provider of trading partner connectivity, integration and unified commerce solutions , has announced today it was positioned in the Leaders category of the IDC MarketScape for Worldwide Multi-Enterprise Supply Chain Commerce Network report. The research states that TrueCommerce offers a broad set of supply chain applications that extend far beyond traditional data transportation. “Our investments into the cutting-edge unified commerce technology and customer care allowed the company to make this qualitative leap, and we are proud to be recognized by such a reputable global research firm as IDC,” said TrueCommerce president Ross Elliott. “The report advises companies to engage with a network vendor that is at least thinking about what tomorrow

UnionBank Launches First Fully Digital Branch in the Philippines15.1.2019 13:30Pressemelding

Appian Cloud Platform Enables Low-Code Rapid Application Development for Powerful Process Automation RESTON, Va. and SYDNEY, Australia , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Appian (NASDAQ: APPN) announces that UnionBank of the Philippines used the Appian Platform to launch its first fully digital branch. The branch, called The Ark, completely transforms the customer experience, making that experience entirely digital, including internet-connected self-service kiosks and virtual reality boxes. Unlike traditional bank branches, The Ark has done away with rows of tellers and long queues, and gone completely paperless. Customers now go to one of the self-service iPad stands stationed around the bank, where they can type in their request, significantly reducing time previously spent waiting in queues for service. “The Ark is an award-winning digital branch that provides a modern experience for our clients within a traditional brick and mortar store,” said Anna Maria Aboitiz Delgado, Head for